CHARTING THE PATH TO
Magellan Bioanalytics applies proprietary AI software to the mass spectra of human blood to find markers to guide precision medicine. Magellan generates human health data by analyzing the "hidden proteome”, a fraction of human sera that contains >120,000 potential biomarkers. Our proprietary technology has successfully identified biomarkers that predict or stage disease in various indications, from breast cancer to Alzheimer's.
Our current research centers on identifying biomarkers that predict patient response to cancer immunotherapy.
We are actively seeking additional partnerships to leverage our technology in other areas of human health.